rs12979860, IFNL4

N. diseases: 84
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE <b>Introduction:</b> IFNL4 rs12979860 genotype CC is associated with increased ALT activity and liver stiffness in hepatitis C virus (HCV) genotype (G) 3 infection but not in G1. 31479286 2019
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE <b>Results:</b> While the rs12979860 IFNL3 T allele was found a good marker associated with HCV-outcome together with the rs111200466 TLR2 del variant, the rs10204525 PD-1.6 A allele was found to have an insignificant role in patients with HCV-related hepatic disorders. 30930876 2019
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE <i>IL28B</i> C/T polymorphism (rs12979860) was evaluated in circulating blood cells using a PCR-based restriction fragment length polymorphism assay.Overall <i>H. pylori</i> serology was positive in 38.1% of our HCV-infected subjects. 29510558 2018
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.900 GeneticVariation BEFREE 41 patients with genotype 1 chronic hepatitis C infection from the Duke Liver Clinic were genotyped for rs12979860. 21750736 2011
Cirrhosis
CUI: C1623038
Disease: Cirrhosis
0.100 GeneticVariation BEFREE Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients. 23936821 2013
Liver Cirrhosis
CUI: C0023890
Disease: Liver Cirrhosis
0.100 GeneticVariation BEFREE Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients. 23936821 2013
Hepatitis B, Chronic
CUI: C0524909
Disease: Hepatitis B, Chronic
0.050 GeneticVariation BEFREE Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study. 24057245 2013
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE In patients achieving rapid virological response, favourable CC/TT allele at rs12979860, rs8099917 was found to be predominant at both the alleles at 77%, 73.2% respectively; whereas in case of patients with relapsed HCV infection CT, TG alleles were found to be predominant. 24914551 2014
Tropical Spastic Paraparesis
CUI: C0030481
Disease: Tropical Spastic Paraparesis
0.020 GeneticVariation BEFREE HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene. 26609200 2015
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE HCV genotype (P=0.007), IFNL3 rs12979860 (CC) (P=0.023), IFNL3 rs12980275 (AA) (P=1 × 10<sup>-4</sup>), EGFR rs11506105 (AA) (P=0.005), RVR (P=1 × 10<sup>-4</sup>), and cEVR (P=0.003) were significant predictors for SVR. 28703131 2017
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE HCV g6-infected rs12979860 major homozygous individuals had significantly higher viral loads than individuals with minor alleles (CC: 6.56 log IU/ml vs. non-CC: 5.66 log IU/ml; P = 0.021). 29022122 2018
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE rs12979860 genotype is a significant independent predictor of response to PEG-IFN/RBV in patients with chronic HCV infection; tests for this genotype might be used to determine the best course of treatment for patients considering antiviral therapy. 20176026 2010
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE rs12979860 and rs8099917 interleukin-28B polymorphisms are associated with spontaneous or interferon-alpha induced hepatitis C clearance, "CC" and "TT" genotypes (respectively) being the most favourable. 24387833 2014
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.900 GeneticVariation BEFREE A comparative study of various methods for detection of IL28B rs12979860 in chronic hepatitis C. 28281380 2017
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A Mexican HCV-1-infected population treated with peg-IFNα and RVB had a low SVR rate, which was associated with the SNP rs12979860 (CC). 23109451 2013
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A new type III interferon, IFN lambda 4 (IFNL4), and its single-nucleotide polymorphism (SNP) ss469415590 causing a frame shift have been recently reported strongly to affect antiviral therapy for chronic hepatitis C virus (HCV) infection in African and Caucasian populations compared to previously reported IL-28B SNPs rs12979860 and rs8099917. 24646752 2014
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.900 GeneticVariation BEFREE A prospective study was conducted including 474 (250 genotype 1, 224 genotype 2) consecutive chronic hepatitis C (CHC) patients who had completed an anti-HCV therapy course and undergone pre-therapy and 24-week post-therapy assessments of interferon λ3-rs12979860 and HCV RNA/genotypes, anthropometric measurements, metabolic and liver profiles, and complement component 3 (C3), C4, and leptin levels. 27870883 2016
Pseudohyperkalemia Cardiff
CUI: C1861453
Disease: Pseudohyperkalemia Cardiff
0.100 GeneticVariation BEFREE A prospective study was conducted including 474 (250 genotype 1, 224 genotype 2) consecutive chronic hepatitis C (CHC) patients who had completed an anti-HCV therapy course and undergone pre-therapy and 24-week post-therapy assessments of interferon λ3-rs12979860 and HCV RNA/genotypes, anthropometric measurements, metabolic and liver profiles, and complement component 3 (C3), C4, and leptin levels. 27870883 2016
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A prospective study was conducted including 474 (250 genotype 1, 224 genotype 2) consecutive chronic hepatitis C (CHC) patients who had completed an anti-HCV therapy course and undergone pre-therapy and 24-week post-therapy assessments of interferon λ3-rs12979860 and HCV RNA/genotypes, anthropometric measurements, metabolic and liver profiles, and complement component 3 (C3), C4, and leptin levels. 27870883 2016
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.900 GeneticVariation BEFREE A significant increase was observed in the frequencies of unfavorable rs12979860 genotypes/CT + TT in the chronic hepatitis C (CHC) and LTC groups. 28214926 2017
Chronic hepatitis C genotype 1
CUI: C4049392
Disease: Chronic hepatitis C genotype 1
0.040 GeneticVariation BEFREE A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus. 21900787 2011
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A single nucleotide polymorphism (rs12979860 C/T) 3kb upstream of the interleukin 28B (IL-28B) gene was shown to be associated with hepatitis C clearance. 21146242 2011
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A single nucleotide polymorphism (SNP) upstream of the IL28 gene (rs12979860) has been reported to predict sustained virological response to peginterferon-ribavirin therapy in chronic HCV patients. 22613675 2012
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.900 GeneticVariation BEFREE A single-nucleotide polymorphism (SNP) near the IL28B gene (rs12979860) strongly predicts sustained virological response to pegylated interferon plus ribavirin (pegIFN-RBV) treatment for chronic hepatitis C virus (HCV) infection. 20964522 2010
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.100 GeneticVariation BEFREE A single-nucleotide polymorphism (SNP; rs12979860) near the IL28B gene has been associated with spontaneous and treatment-induced hepatitis C virus clearance. 23784926 2013